Core Insights - Evogene Ltd. has appointed Mr. Nir Nimrodi as the new Chairperson of the Board, succeeding Ms. Sarit Firon, who will remain a Board member [1][2] - Mr. Nimrodi's extensive experience in scaling life sciences businesses positions him well to guide Evogene through its next growth phase [2][3] - The company aims to leverage advanced computational capabilities and AI to enhance drug discovery processes and create significant value for shareholders [3] Company Overview - Evogene Ltd. is a computational biology company focused on revolutionizing life-science product development through big data and artificial intelligence [4] - The company has established three unique tech-engines: MicroBoost AI, ChemPass AI, and GeneRator AI, each targeting different core components for product development [5] Subsidiaries and Focus Areas - Evogene operates four subsidiaries: 1. Casterra Ag Ltd. focuses on high-yield castor seed varieties for biofuel and other industries [6] 2. Lavie Bio Ltd. develops microbiome-based ag-biologicals [6] 3. AgPlenus Ltd. works on next-generation ag chemicals for sustainable crop protection [6] 4. Biomica Ltd. is advancing microbiome-based therapeutics for human disorders [6]
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025